National Health Insurance Act Article 41
The Fee Schedule and Reference List for Medical Services shall be established jointly by the Insurer and the relevant agencies, experts, beneficiaries, employers, and contracted medical care providers and reported to the Competent Authority for approval.The drug dispensing items and fee schedule shall be established jointly by the Insurer and the relevant agencies, experts, beneficiaries, employers, and contracted medical care providers; drug providers and relevant experts, as well as patients, shall also be invited to voice their opinions and reported to the Competent Authority for approval.The drafting of the two abovementioned standards shall be in accordance with the medical needs of the insured as well as the quality of medicine. The meeting shall be accurately recorded; self-disclosure of the representatives’ interests and other relevant information shall be made public. The results of the Insurer’s medical technology evaluation shall be made public before the drafting process begins.The joint drafting of the procedures in Paragraphs 1 and 2, as well as the drawing up of the list of representatives, its selection process, term of office, disclosure of interests, and other relevant information, shall be determined by the Competent Authority.
中文原文 全民健康保險法第41條
醫療服務給付項目及支付標準，由保險人與相關機關、專家學者、被保險人、雇主及保險醫事服務提供者等代表共同擬訂，報主管機關核定發布。
藥物給付項目及支付標準，由保險人與相關機關、專家學者、被保險人、雇主、保險醫事服務提供者等代表共同擬訂，並得邀請藥物提供者及相關專家、病友等團體代表表示意見，報主管機關核定發布。
前二項標準之擬訂，應依被保險人之醫療需求及醫療給付品質為之；其會議內容實錄及代表利益之自我揭露等相關資訊應予公開。
於保險人辦理醫療科技評估時，其結果並應於擬訂前公開。
第一項及第二項共同擬訂之程序與代表名額、產生方式、任期、利益之揭露及資訊公開等相關事項之辦法，由主管機關定之。
藥物給付項目及支付標準，由保險人與相關機關、專家學者、被保險人、雇主、保險醫事服務提供者等代表共同擬訂，並得邀請藥物提供者及相關專家、病友等團體代表表示意見，報主管機關核定發布。
前二項標準之擬訂，應依被保險人之醫療需求及醫療給付品質為之；其會議內容實錄及代表利益之自我揭露等相關資訊應予公開。
於保險人辦理醫療科技評估時，其結果並應於擬訂前公開。
第一項及第二項共同擬訂之程序與代表名額、產生方式、任期、利益之揭露及資訊公開等相關事項之辦法，由主管機關定之。